Double Dividend Stocks | Apr 26, 2015 01:12AM ET
The US dollar had a mixed week, and fell vs. major currencies, except for the yen, Swiss franc, and New Zealand dollar:
Week Ahead Highlights: Healthcare stocks will be in focus, with many top companies reporting first-quarter earnings, including Bristol-Myers Squibb Company (NYSE:BMY), Boston Scientific Corp (NYSE:BSX) , Merck & Co. (NYSE:MRK), Pfizer Inc (NYSE:PFE), Gilead Sciences Inc (NASDAQ:GILD) and Celgene Corp (NASDAQ:CELG). Apple (NASDAQ:AAPL) reports on Monday after the close…the Fed will issue a statement on Wednesday, after its 2-day meeting…Q1 GDP figures will also be issued on 4/29, and may move markets.
Next Week’s US Economic Reports:
Tech led this past week, led by Microsoft (NASDAQ:MSFT)’s post-earnings surge:
Disclaimer: This article is written for informational purposes only, and isn’t intended as investment advice.
Disclosure: Author owned shares of CCLP at the time this article was published.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.